LILAK
Liberty Latin America Ltd.
LILAK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
META
Meta Platforms, Inc.
META has the edge over LILAK overall, supported by lower modeled downside and stronger valuation.
LILAK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
LILAK's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LILAK PE Valuation
LILAK has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
LILAK Forward outlook
There aren't enough analyst estimates for LILAK to show an outlook.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
LILAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.90 | +$2.43 |
| Q2 2026 | -$0.46 | +$4.90 |
| Q1 2026 | -$2.25 | +$1.39 |
| Q4 2025 | -$2.78 | +$0.23 |
| Q3 2025 | -$3.33 | -$0.58 |
| Q2 2025 | -$5.36 | -$4.90 |
| Q1 2025 | -$3.64 | -$3.53 |
| Q4 2024 | -$3.01 | -$2.69 |
LILAK is still losing money, but far less than before: $0.90 per share over the past year, against $5.36 at its worst in mid-2025.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over LILAK on earnings quality, reporting a profit while its opponent remains loss making.
LILAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +0.4% |
| Q2 2026 | $1.1B | +1.5% |
| Q1 2026 | $1.1B | -0.1% |
| Q4 2025 | $1.2B | +0.8% |
| Q3 2025 | $1.1B | +2.1% |
| Q2 2025 | $1.1B | -2.8% |
| Q1 2025 | $1.1B | -1.4% |
| Q4 2024 | $1.2B | -1.1% |
LILAK's revenue grew through 2022 and has held roughly level since: $1.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -0.6 points |
| Q2 2026 | 16% | +47 points |
| Q1 2026 | 13% | +1.6 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 17% | +52 points |
| Q2 2025 | -31% | -41 points |
| Q1 2025 | 12% | +3.4 points |
| Q4 2024 | 11% | +1.4 points |
LILAK's operating margin was 16% last quarter, down 0.6 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over LILAK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over LILAK on profitability, with a higher operating margin.
LILAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.2M | -21% |
| Q2 2026 | $96M | +4953% |
| Q1 2026 | -$57.1M | +$15M |
| Q4 2025 | $320.1M | +36% |
| Q3 2025 | $56M | +9.8% |
| Q2 2025 | $1.9M | -88% |
| Q1 2025 | -$72.1M | +$14.3M |
| Q4 2024 | $234.9M | +2.8% |
LILAK has the edge over META on cash flow, with more consistent year-over-year improvement.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
LILAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.2% | -6.4M shares |
| 1 year | -15% | -33.8M shares |
| 3 years | -15% | -34.8M shares |
| 5 years | -30% | -84.1M shares |
| Available history | -8.4% | -17.9M shares |
LILAK has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $90.9M |
| Q2 2026 | $12.1M |
| Q1 2026 | $14.3M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
LILAK spent $117M buying back its own shares over the past year, after none the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
LILAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.1x | High |
| Q2 2026 | 5.0x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 7.4x | High |
| Q3 2025 | 7.6x | High |
| Q2 2025 | 16.2x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 8.1x | High |
LILAK's net debt is about 5.0 years of its operating earnings (EBITDA), down from 7.6 years a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META has the edge over LILAK on leverage, with a lower net debt burden relative to earnings.
LILAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.0 | Neutral |
| Stochastic | 72.3 | Neutral |
LILAK's weekly RSI is 65 (neutral) and its Stochastic is 72 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
LILAK PE vs Communication Services Sector
| Metric | LILAK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
LILAK has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
LILAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.53 | 15% above |
| 20 week MA | $8.26 | 18% above |
| 50 week MA | $8.03 | 22% above |
| 100 week MA | $7.43 | 31% above |
| 200 week MA | $7.80 | 25% above |
LILAK has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
LILAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $11.2 | -43% |
| 2021 | $11.2 | $11.5 | +2.1% |
| 2022 | $11.5 | $7.74 | -33% |
| 2023 | $7.74 | $7.34 | -5.2% |
| 2024 | $7.34 | $6.38 | -13% |
| 2025 | $6.38 | $7.59 | +19% |
| 2026 YTD | $7.59 | $9.77 | +29% |
LILAK has the edge over META on returns for 2026, with the stronger performance.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.